BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25416104)

  • 21. E3 ubiquitin ligase Siah-1 facilitates poly-ubiquitylation and proteasomal degradation of the hepatitis B viral X protein.
    Zhao J; Wang C; Wang J; Yang X; Diao N; Li Q; Wang W; Xian L; Fang Z; Yu L
    FEBS Lett; 2011 Oct; 585(19):2943-50. PubMed ID: 21878328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop.
    Steffen J; Seeger M; Koch A; Krüger E
    Mol Cell; 2010 Oct; 40(1):147-58. PubMed ID: 20932482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteasome and oxidative phoshorylation changes may explain why aging is a risk factor for neurodegenerative disorders.
    Zabel C; Nguyen HP; Hin SC; Hartl D; Mao L; Klose J
    J Proteomics; 2010 Oct; 73(11):2230-8. PubMed ID: 20813214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of the ubiquitin-proteasome system in neurosurgery and the clinical applications of protein therapy].
    Michiue H; Date I
    No Shinkei Geka; 2014 Oct; 42(10):899-906. PubMed ID: 25266580
    [No Abstract]   [Full Text] [Related]  

  • 25. Enhanced Degradation of Misfolded Proteins Promotes Tumorigenesis.
    Chen L; Brewer MD; Guo L; Wang R; Jiang P; Yang X
    Cell Rep; 2017 Mar; 18(13):3143-3154. PubMed ID: 28355566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neurodegenerative diseases regulated by ubiquitin-proteasome system].
    Hatakeyama S
    Seikagaku; 2005 May; 77(5):389-99. PubMed ID: 15952328
    [No Abstract]   [Full Text] [Related]  

  • 27. Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication.
    Dohm CP; Kermer P; Bähr M
    Neurodegener Dis; 2008; 5(6):321-38. PubMed ID: 18309232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Functions of carboxyl-terminus of Hsc70 interacting protein and its role in neurodegenerative disease].
    Yan WQ; Wang JL; Tang BS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Aug; 29(4):426-30. PubMed ID: 22875499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age: the randomized Leipzig Exercise Intervention in Chronic Heart Failure and Aging catabolism study.
    Gielen S; Sandri M; Kozarez I; Kratzsch J; Teupser D; Thiery J; Erbs S; Mangner N; Lenk K; Hambrecht R; Schuler G; Adams V
    Circulation; 2012 Jun; 125(22):2716-27. PubMed ID: 22565934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lessons from p53 in non-mammalian models.
    Lu WJ; Abrams JM
    Cell Death Differ; 2006 Jun; 13(6):909-12. PubMed ID: 16557266
    [No Abstract]   [Full Text] [Related]  

  • 31. Proteasome activation delays aging in vitro and in vivo.
    Chondrogianni N; Sakellari M; Lefaki M; Papaevgeniou N; Gonos ES
    Free Radic Biol Med; 2014 Jun; 71():303-320. PubMed ID: 24681338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of ubiquitin-proteasome proteolysis in muscle fiber destruction in experimental chloroquine-induced myopathy.
    Kimura N; Kumamoto T; Oniki T; Nomura M; Nakamura K; Abe Y; Hazama Y; Ueyama H
    Muscle Nerve; 2009 Apr; 39(4):521-8. PubMed ID: 19296457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?
    Dennissen FJ; Kholod N; van Leeuwen FW
    Prog Neurobiol; 2012 Feb; 96(2):190-207. PubMed ID: 22270043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ubiquitin ligase COP1 is a critical negative regulator of p53.
    Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
    Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug discovery in the ubiquitin-proteasome system.
    Nalepa G; Rolfe M; Harper JW
    Nat Rev Drug Discov; 2006 Jul; 5(7):596-613. PubMed ID: 16816840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
    Uruno A; Motohashi H
    Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteasome Activation as a New Therapeutic Approach To Target Proteotoxic Disorders.
    Njomen E; Tepe JJ
    J Med Chem; 2019 Jul; 62(14):6469-6481. PubMed ID: 30839208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZOMES: the intriguing interplay of PCI complexes and the ubiquitin in protein homeostasis.
    Alpi AF; Echalier A
    Cell Death Dis; 2017 Aug; 8(8):e3021. PubMed ID: 28837155
    [No Abstract]   [Full Text] [Related]  

  • 39. Activation of Nrf2 signaling as a common treatment of neurodegenerative diseases.
    Dinkova-Kostova AT; Kazantsev AG
    Neurodegener Dis Manag; 2017 Apr; 7(2):97-100. PubMed ID: 28534719
    [No Abstract]   [Full Text] [Related]  

  • 40. Priming the Proteasome to Protect against Proteotoxicity.
    Wang X; Wang H
    Trends Mol Med; 2020 Jul; 26(7):639-648. PubMed ID: 32589934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.